Opioid Overdose – Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report

The term “opioids” encompasses compounds derived from the poppy plant (Papaver somniferum), along with semisynthetic and synthetic counterparts sharing similar properties that can engage with opioid receptors in the brain. Opioids, such as morphine, codeine, and fentanyl, are commonly employed for pain management due to their analgesic and sedative effects. Medications like methadone and buprenorphine are used for the maintenance treatment of opioid dependence. Upon ingestion, opioids can induce euphoria, a primary motivator for their non-medical use. This category includes substances like heroin, tramadol, and others. Owing to their pharmacological impact, opioids can pose risks to respiratory function, and an opioid overdose can result in fatality. Three indicative signs of an opioid overdose include pinpoint pupils, unconsciousness, and breathing difficulties. An opioid overdose transpires when there is an excessive, unopposed stimulation of the opiate pathway, leading to diminished respiratory effort and potential death. The incidence of opioid overdose is on the rise. Opioids operate by acting as potent agonists to the mu receptor within the endogenous opioid system, triggering a complex cascade of signals that involve dopamine release, pain signal blockade, and the emergence of euphoria. Opioid receptors are distributed in the brain, spinal cord, and gut. During an overdose, an exaggerated impact on the brain’s respiratory rate regulation can result in respiratory depression and, ultimately, death.
• In the United States, more than 20 million people have been exposed to opium, contributing to the escalating frequency of opioid-related issues.

Thelansis’s “Opioid Overdose Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2023 To 2033″ covers disease overview, epidemiology, drug utilization, prescription share analysis, competitive landscape, clinical practice, regulatory landscape, patient share, market uptake, market forecast, and key market insights under the potential Opioid Overdose treatment modalities options for eight major markets (USA, Germany, France, Italy, Spain, UK, Japan, and China).

KOLs insights of Opioid Overdose across 8 MM market from the centre of Excellence/ Public/ Private hospitals participated in the study. Insights around current treatment landscape, epidemiology, clinical characteristics, future treatment paradigm, and Unmet needs.
Opioid Overdose Market Forecast Patient Based Forecast Model (MS. Excel Based Automated Dashboard), which Data Inputs with sourcing, Market Event, and Product Event, Country specific Forecast Model, Market uptake and patient share uptake, Attribute Analysis, Analog Analysis, Disease burden, and pricing scenario, Summary, and Insights.
Thelansis Competitive Intelligence (CI) practice has been established based on a deep understanding of the pharma/biotech business environment to provide an optimized support system to all levels of the decision-making process. It enables business leaders in forward-thinking and proactive decision-making. Thelansis supports scientific and commercial teams in seamless CI support by creating an AI/ ML-based technology-driven platform that manages the data flow from primary and secondary sources.
Read more: Opioid Overdose – Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2023 To 2033
Tags: Opioid Overdose, Opioid Overdose market outlook, Opioid Overdose competitive landscape, Opioid Overdose market forecast, Thelansis, Primary market research, KOL insights, Competitive Intelligence (CI)